Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial

Datoo MS., Natama HM., Somé A., Bellamy D., Traoré O., Rouamba T., Tahita MC., Ido NFA., Yameogo P., Valia D., Millogo A., Ouedraogo F., Soma R., Sawadogo S., Sorgho F., Derra K., Rouamba E., Ramos-Lopez F., Cairns M., Provstgaard-Morys S., Aboagye J., Lawrie A., Roberts R., Valéa I., Sorgho H., Williams N., Glenn G., Fries L., Reimer J., Ewer KJ., Shaligram U., Hill AVS., Tinto H.

DOI

10.1016/s1473-3099(22)00442-x

Type

Journal article

Publisher

Elsevier BV

Publication Date

2022-12-01T00:00:00+00:00

Volume

22

Pages

1728 - 1736

Total pages

8

Permalink More information Close